GLC Biotechnology, Inc.

Early Colon Cancer Screening

Hudson, United States · Founded 2016 · $7.8M raised

Headquarters
Hudson, Ohio
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$7.8M
Last Round
$6.6M GrantJan 2023
Rounds
2

About

GLC Biotechnology develops next-generation stool DNA diagnostics using proprietary patented technology aimed at early colon cancer detection. Its flagship test targets pre-cancerous polyp detection at an 82% rate, offering a non-invasive alternative to colonoscopy for mass-market colorectal cancer screening.

Summary

GLC Biotechnology, Inc. is a Biotech company based in Hudson, United States, founded in 2016. It has raised $7.8M in total across 2 rounds, most recently a $6.6M Grant round in Jan 2023. Investors include National Institutes of Health.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2023
$6.6M

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GLC Biotechnology, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/glc-biotechnology-inc"><img src="https://indexed.vc/api/badge/company/glc-biotechnology-inc" alt="GLC Biotechnology, Inc. on Indexed.vc" width="260" height="76" /></a>